128 related articles for article (PubMed ID: 6727048)
1. [Study of immunosuppressive acidic protein (IAP) in patients with renal cell cancer].
Shibayama T; Nakazono M; Koyama Y; Deguchi N; Baba S; Jitsukawa S; Murai M; Tazaki H
Gan No Rinsho; 1984 May; 30(5):481-6. PubMed ID: 6727048
[TBL] [Abstract][Full Text] [Related]
2. [Immunosuppressive acidic protein (IAP) and immunosuppressive substance (ISS) in patients with renal cell carcinoma].
Yamazaki K; Kumamoto Y; Tsukamoto T; Ohmura K; Miyao N; Yoshioka M; Iwasawa A
Hinyokika Kiyo; 1991 May; 37(5):467-74. PubMed ID: 1858580
[TBL] [Abstract][Full Text] [Related]
3. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy.
Araki K; Igarashi T; Tobe T; Mizoguchi K; Suzuki H; Furuya Y; Ichikawa T; Nakatsu HO; Ito H
Urology; 2006 Dec; 68(6):1178-82. PubMed ID: 17141843
[TBL] [Abstract][Full Text] [Related]
4. [Study on serum levels of immunosuppressive acidic protein (IAP) as a marker of renal cell carcinoma].
Hoshino M; Fuji K; Kataoka K; Inoue K; Higaki Y; Imamura K
Hinyokika Kiyo; 1989 Oct; 35(10):1647-52. PubMed ID: 2610170
[TBL] [Abstract][Full Text] [Related]
5. [An evaluation of carcinoembryonic antigen (CEA), beta 2-microglobulin (BMG), and immunosuppressive acidic protein (IAP) in the serum of primary lung cancer patients].
Higuchi Y
Gan No Rinsho; 1986 Jan; 32(1):33-40. PubMed ID: 3005690
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of measurement of immunosuppressive acidic protein (IAP) in lung cancer].
Kondo H; Seno N; Matsuo S; Otagaki S; Matsuki T; Hatayama T
Gan To Kagaku Ryoho; 1983 Oct; 10(10):2163-70. PubMed ID: 6625623
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive acidic protein detects high nuclear grade localized renal cell carcinoma.
Kawata N; Yamaguchi K; Hirakata H; Hachiya T; Yoshida T; Takimoto Y
Urology; 2005 Oct; 66(4):736-40. PubMed ID: 16230127
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of immunosuppressive acid protein in genitourinary malignant diseases].
Okada S; Kirime S; Kawasaki T; Kanbara A; Kanehara H; Takasaki N; Miyazaki S; Inai S
Hinyokika Kiyo; 1988 Mar; 34(3):411-8. PubMed ID: 3389287
[TBL] [Abstract][Full Text] [Related]
9. [Inflammatory reaction and laboratory tests: IAP (immunosuppressive acidic protein)].
Sato T; Sakata Y; Tamura K
Rinsho Byori; 1990 Mar; 38(3):255-9. PubMed ID: 2190023
[TBL] [Abstract][Full Text] [Related]
10. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
[TBL] [Abstract][Full Text] [Related]
11. [Clinical investigation of serum immunosuppressive acidic protein (IAP) in patients with gastric cancer].
Kageyama T; Oyabu H; Ohshiba S
Gan No Rinsho; 1986 Sep; 32(11):1416-20. PubMed ID: 3773269
[TBL] [Abstract][Full Text] [Related]
12. [Immunosuppressive acidic glycoprotein (IAP) and immunosuppressive substance].
Ogoshi K; Kondoh Y; Nakasaki H; Tajima T; Mitomi T
Gan No Rinsho; 1983 Aug; 29(9):987-90. PubMed ID: 6688640
[TBL] [Abstract][Full Text] [Related]
13. Serum level of immunosuppressive acidic protein in patients with urological malignancies.
Pu YS; Tsai TC; Chiu TY; Hsieh TS; Chen J; Chen SC; Lin MC; Hsu TC
J Formos Med Assoc; 1991 May; 90(5):498-503. PubMed ID: 1680990
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study on the serum carcinoembryonic antigen, immunosuppressive acidic protein and C-reactive protein levels in patients with adult T cell leukemia].
Kumagai E; Ogata M; Maeda Y; Kumagai T; Okajima K; Yamaguchi K; Tanoue S
Rinsho Byori; 1989 Jul; 37(7):769-73. PubMed ID: 2607647
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive acidic protein (IAP) and squamous cell carcinoma antigen (SCC) in patients with cervical cancer.
Battaglia F; Scambia G; Panici PB; Castelli M; Ferrandina G; Foti E; Amoroso M; D'Andrea G; Mancuso S
Gynecol Oncol; 1994 May; 53(2):176-82. PubMed ID: 8188076
[TBL] [Abstract][Full Text] [Related]
16. [Studies on immunosuppressive acidic protein (IAP) in ovarian tumors].
Miyoshi T; Nishimura H; Hamai J; Yamada T; Tomoo Y; Kobayashi H; Yakushiji M; Kato T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):923-9. PubMed ID: 2991397
[TBL] [Abstract][Full Text] [Related]
17. [Immunosuppressive acidic protein (IAP) in gynecologic malignant tumors and its relationship with other immunosuppressive substances and cell-mediated immunity].
Takada M
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):237-44. PubMed ID: 6881975
[TBL] [Abstract][Full Text] [Related]
18. [Immunosuppressive acidic protein in patients with gynecologic cancer].
Sawada M; Matsui Y; Okudaira Y; Shimizu Y; Takayama K
Nihon Sanka Fujinka Gakkai Zasshi; 1983 May; 35(5):605-11. PubMed ID: 6408203
[TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of the serum level of immunosuppressive acidic protein (IAP) and immunosuppressive substance (IS) in gastric cancer patients].
Sakita M; Yamane T; Kasuga M; Torii T; Imai H; Kageyama N; Fujita Y; Majima S
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1755-64. PubMed ID: 7184372
[TBL] [Abstract][Full Text] [Related]
20. [Variations in the level of immunosuppressive acidic protein in patients with gynecologic tumors and pregnant women].
Sawada M; Okudaira Y; Matsui Y; Miyoshi Y; Takayama K; Shimizu Y; Miura S
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1823-30. PubMed ID: 6882005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
